High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab. [electronic resource]

By: Contributor(s): Publication details: Cancer management and research 2020Description: 475-484 p. digitalISSN:
  • 1179-1322
Online resources: In: Cancer management and research vol. 12
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.